What Happened: Microglia‘s Role in Adolescent Brain Development

The brain’s immune cells, specifically‌ microglia, are crucial for the development and adaptation of the adolescent brain, according to new research conducted on ⁢mice. This revelation could substantially impact how neurodevelopmental disorders like schizophrenia and ADHD⁢ are treated.

Executive ​functions – such as making a smoothie, taking an evening walk, or demonstrating empathy – are controlled ⁤by the brain’s frontal cortex.⁣ this area undergoes ‍ample ⁣changes during adolescence, making it​ a critical⁢ period for‌ brain development and a time when circuit abnormalities can contribute to neurodevelopmental disorders.

Researchers found that microglia play a key role in how the brain adapts to these changes during‍ adolescence. This finding suggests potential new therapeutic targets for these disorders, not just⁤ during adolescence⁤ but possibly into adulthood.

understanding Microglia and Dopaminergic Circuits

The study focuses on microglia, the brain’s resident immune cells. These cells are not simply defenders against infection; they actively participate in shaping the brain’s circuitry.

Dopaminergic circuits, networks of neurons that use dopamine to transmit details, are also central to this process. These circuits are​ particularly susceptible to change during adolescence, and previous ‌research from the same lab demonstrated that both direct activation of these circuits and rewarding behaviors can‍ drive plasticity – the⁣ brain’s ⁤ability‌ to reorganize itself – during this period.

Key Findings and Implications

The research highlights that microglia influence the plasticity of dopaminergic connections to ⁣the​ frontal cortex specifically during adolescence. This suggests that manipulating microglial activity could potentially enhance or correct circuit development in individuals at risk for or diagnosed with neurodevelopmental ⁣disorders.

“A better understanding ‍of the ways‍ we can drive changes in ⁢these circuits offers new targets for disease treatment,” says Rianne Stowell, ‍research assistant⁣ professor of neuroscience at the University of Rochester Medical Center, and​ first author of the study published in nature Communications.